Abstract:Objectives This study aimed to investigate the efficacy in patients with acute coronary syndrome using high-dose statins during the period of hospitalization as well as to observe the security.Methods A total of 67 selected patients are enrolled In this study.Patients are randomly divided into high-dose atorvastatin(n=41) and low-dose atorvas-tatin (n=26).We choose 5-day for the period of observation in this study.We give atorvastatin-20 mg per night for maintenance therapy in low-dose atorvastatin group.We give ator-vastatin -80 mg per night for maintenance therapy for 5-say and 20 mg per night from the 6th day in high-dose atorvastatin. Conventional therapy is given according to the patients situation and low-salt low-fat diet is given.UA、CRP and Fbg are measured at baseline and at 24 hours and? after 5-day. Lipid,liver function and renal function are measured at the 2nd day and the 6th day.Results(1)The two groups are similar with UA,CRP and Fbg at the time of procedural. The decline of UA,CRP are significantly more in two groups at 24-hours(P<0.001);but Fbg has no decline.The decline of UA:7.0%vs.10.4%(P=0.060),CRP:32.2%vs.42.5% (P=0.012),UA and CRP are both lower than at 24-hour in two groups(P<0.001),the decline of UA:10.9%vs.14.9% (P=0.259),CRP:76.3%vs.84.9%(P=0.035),Fbg is higher than at 24-hour in two groups,but has no significantly in two groups 37.7%vs.38.4%(P=0.700).(2) At 5-day clinical follow-up,3.8%of the cases occured MACE in placebo and 0%in atotvastatin group(3.8%vs.0%,P= 0.016),the other adverse events(9.6%vs.1.8%,P=0.004). TC,TG and HDL have no significant change,LDL decline in two groups,but has no difference between groups.(3) 8 patients have a increase in ALT after 5-day in low-dose atotvastatin group and 21 in high-dose atotvastatin group(31% vs.51%,P=0.059),no patient quit the research because ALT increase>3times.Both groups have a increase in BUN and Crs(BUN 46%vs.66%,P=0.057,Crs 58%vs.77%,P= 0.055).Conclutions(1)Early use of high-dose atorvastadn in ACS can reduce uric acid and c-reactive protein.Fbg has a ascent with the period of treatment.(2) Taking high-dose of atorvastatin in patients with ACS during hospitalization reduce the occurrence of MACE better than taking low-dose, and has nothing to do with lipid-lowing effect.(3) The use of high dose atorvastatin does not reduce drug use safety.

Effects of Different Doses of Simvastatin on Acute Coronary Syndrome

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

The Effect of Simvastatin and Pravastatin on Serum Lipid and C Reactive Protein in Patients with Acute Coronary Syndrome

Lipid-lowering Efficacy and Safety of Simvastatin in Different Dosage in Patients with Early-Period of Acute Coronary Syndrome

Anti-myocardial Ischemic Effects of Simvastatin on Patients with Stable Angina Pectoris and Average Lipid Levels

The efficacy and safety of different doses of simvastatin in treatment of patients with coronary artery disease

Effect of Simvastatin on Acute Coronary Syndrome Complicated with Atrial Fibrillation

The effect of simvastatin on C reactive protein in patients with coronary heart disease

Lipid-lowering Efficacy and Safety of Varying Doses of Simvastatin in Patients with Early Stage Acute Coronary Syndromes： One-Year Follow-Up Study

Effect of Simvastatin on Serum Level of Inflammatory Factors in Acute Coronary Syndrome

Effects of Different Doses of Simvastatin on Plasma Levels of Tissue Factor and Tissue Factor Pathway Inhibitor in Patients with Acute Coronary Syndromes

Effects on simvastatin on the atherosclerotic plaques of carotid artery in elderly patients with normal lipidenia level

Effectiveness and Safety of Simvastatin 40 mg Daily Use in Treatment of Coronary Heart Disease

Effect of Simvastatin Upon Serum Levels of Interleukin-6 and High-Sensitivity C-reactive Protein in Patients with Acute Coronary Syndrome

Association of Lipid-Lowing Efficacy and Safety of Short-Term Statins Therapy with Different Dosages

Effect of different dose of atorvastatin on plasma soluble OX40L level in patients with acute coronary syndrome

Effects of Simvastatin on Artherosclerosis of Common Carotid Artery in Patients with Coronary Artery Disease

Effect of Different Doses of Atorvastatin on Serum Lipid and Inflammatory Factor Hs-Crp in Patients with Coronary Artery Disease

Clinical study on the effect and security of different doses of rosuvastatin therapy in acute coronary syndrome ;patients with diabetes

Effects Of Different Doses Of Atorvastatin On Blood Lipids, Cardiac Function And Prognosis In Elderly Patients With Acute Myocardial Infarction

Early and extensive use of statins in patients with acute coronary syndrome